Andrew D. Goodman, M.D.

Andrew D. Goodman, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 605
Rochester, NY 14642

Office: (585) 275-7854
Fax: (585) 275-9953
Administrative: (585) 275-7854

Professional Bio

Andrew D. Goodman, MD is Professor of Neurology, Chief of the Neuroimmunology Unit, and Director of the Multiple Sclerosis Center at the University of Rochester.

Dr. Goodman is a graduate of Rutgers College and the University of Medicine and Dentistry of New Jersey; he did residency training in internal medicine and neurology at Mt. Sinai Medical Center in New York City. He completed a research fellowship in the Neuroimmunology Branch at the National Institutes of Health, Bethesda, Maryland.

Numerous publications reflect his interests in clinical and experimental therapeutics research as well as the immunology and virology of multiple sclerosis. Dr. Goodman has been principal investigator and a member of national and international steering committees for numerous clinical trials of new therapies for multiple sclerosis.

Dr. Goodman is a past Chair of the Multiple Sclerosis Section of the American Academy of Neurology. He has served the National Multiple Sclerosis Society as Deputy Medical Officer, Co-Chair of the Long-term Care Committee, member of the Client Education Committee, and member of the Executive Committee of the National Clinical Advisory Board.

Awards & Honors (National)

Inductee, Volunteer Hall of Fame | US National Multiple Sclerosis Society | New Orleans, LA 2001

Awards & Honors (Local)

Fellow, American Academy of Neurology 2005
Impact Presentation Award, Congress of the European Committee for Treatment and Research in Multiple Sclerosis | Vienna 2004
Senior Faculty Award | University of Rochester Department of Neurology | Rochester, NY 2003
Chair, Multiple Sclerosis Section | American Academy of Neurology 1999 - 2000
Chair-elect, Multiple Sclerosis Section | American Academy of Neurology 1998 - 1999
Named in Best Doctors in America 1998 - Present
University of Rochester Neurology Resident Faculty Teaching Award | Rochester, NY 1997
Named in Best Doctors in America: Northeast. 1996 - Present
Chief Neurology Resident | Mount Sinai Medical Center 1982 - 1983
Alpha Omega Alpha 1979
A.B. with Distinction in Biochemistry 1974
Henry Rutgers Scholar 1973 - 1974

Recent Journal Articles

Showing the 5 most recent journal articles. 72 available »

2016 Mar 12
Lublin F, Miller DH, Freedman MS, Cree BA, Wolinsky JS, Weiner H, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BM, Merschhemke M, Li B, Putzki N, Liu FC, Häring DA, Kappos L, . "Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial." Lancet. 2016 Mar 12; 387(10023):1075-84. Epub 2016 Jan 28.
2015 Dec 1
Applebee A, Goodman AD, Mayadev AS, Bethoux F, Goldman MD, Klingler M, Blight AR, Carrazana EJ. "Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial." Clinical therapeutics. 2015 Dec 1; 37(12):2780-7. Epub 2015 Nov 10.
2012 Nov 24
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA, . "Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial." Lancet. 2012 Nov 24; 380(9856):1829-39. Epub 2012 Nov 01.
2012 Nov 24
Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Fisher E, Brinar VV, Giovannoni G, Stojanovic M, Ertik BI, Lake SL, Margolin DH, Panzara MA, Compston DA, . "Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial." Lancet. 2012 Nov 24; 380(9856):1819-28. Epub 2012 Nov 01.
2012 Feb
Kinkel RP, Dontchev M, Kollman C, Skaramagas TT, O'Connor PW, Simon JH, . "Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance." Archives of neurology. 2012 Feb; 69(2):183-90. Epub 2011 Oct 10.

Current Appointments

Professor - Department of Neurology, Neuroimmunology (SMD) - Primary


Neurology - American Board of Psychiatry and Neurology


MD | Medicine | Coll of Medicine & Dentistry1979
BA | Arts & Sciences | Rutgers State University1974

Post-Doctoral Training & Residency

Fellowship in Neurology at National Institute of Health09/01/1983 - 06/30/1988
Residency in Neurology at Mount Sinai Medical Center09/01/1980 - 06/30/1983
Residency in Medicine at Mount Sinai Medical Center09/01/1979 - 06/30/1980